Maastricht UMC+
Maastricht, Netherlands
19 recruiting
Showing 1–20 of 31 trials
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Relapsed or Refractory Multiple Myeloma (RRMM)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company440 enrolled141 locationsNCT06615479
Recruiting
Phase 1Phase 2
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Relapsed/Refractory Non-Hodgkin Lymphoma
Bristol-Myers Squibb460 enrolled67 locationsNCT06090539
Recruiting
Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company700 enrolled366 locationsNCT06890598
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer MetastaticNon-Small-Cell Lung CarcinomaNon-small Cell Carcinoma
Pfizer680 enrolled402 locationsNCT07144280
Recruiting
Phase 3
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small Cell Lung
Mirati Therapeutics Inc.630 enrolled351 locationsNCT06875310
Recruiting
Not Applicable
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
HypertensionHypertension, SystolicHypertension,Essential
Orchestra BioMed, Inc316 enrolled131 locationsNCT06059638
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled270 locationsNCT06152575
Recruiting
Phase 2Phase 3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation534 enrolled71 locationsNCT04910685
Recruiting
Phase 2
Tarlatamab for SCLC Brain Metastases
Brain Metastases, AdultSmall Cell Lung Cancer
Maastricht University Medical Center35 enrolled4 locationsNCT07402343
Recruiting
Not Applicable
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Metastatic
University Medical Center Groningen100 enrolled3 locationsNCT05864794
Recruiting
Phase 2
Boosting Osimertinib Blood Brain Barrier Penetration
Non-small Cell Lung Cancer
Maastricht University Medical Center7 enrolled2 locationsNCT07485452
Recruiting
Prospective Data Collection Initiative on Colorectal Cancer
Colorectal, Cancer
Dutch Colorectal Cancer Group50,000 enrolled70 locationsNCT02070146
Recruiting
Phase 4
Staphylococcus Aureus Network Adaptive Platform Trial
Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled161 locationsNCT05137119
Recruiting
Phase 3
TMS for Exposure Therapy Resistant OCD
1 Hz Real rTMS to the Pre-SMA1 Hz Sham rTMS to the Pre-SMA
Amsterdam UMC, location VUmc250 enrolled8 locationsNCT05331937
Recruiting
Not Applicable
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Parkinson DiseaseDeep Brain Stimulation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)130 enrolled4 locationsNCT06909045
Recruiting
Phase 4
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek200 enrolled7 locationsNCT07160231
Recruiting
Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System and the BeGraft Peripheral Stent Graft System Treating Aortic-iliac Occlusive Disease
Aorto Iliac Occlusive Disease
Marc Bosiers, MD109 enrolled15 locationsNCT05805111
Recruiting
The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment
Colorectal Neoplasms
Maastricht University Medical Center104 enrolled1 locationNCT05655780
Recruiting
Phase 3
MAD Trial: Myopia Atropine Dose
Progressive myopia
Erasmus Medical Center550 enrolled20 locationsNCT05667454
Recruiting
Not Applicable
FMRI-neurofeedback in Depression
Depression, Unipolar
Maastricht University Medical Center120 enrolled3 locationsNCT05640089